home All News open_in_new Full Article

El 'Juego de Tronos' de las farmas en el negocio de la obesidad

La 'biotech' Metsera se ha decantado por Pfizer, que entra con su compra en el floreciente mercado de la obesidad, en detrimento de Novo, que no quiere perder terreno frente a Lilly. Leer


today 4 d. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 2248983796
Add Watch Country

arrow_drop_down